CASP9 and neoplasm: Caspase-9 inhibition restored the TRAIL-mediated reduction in tumor sphere size (Fig. 5a) and strongly suppressed TRAIL-mediated cell death and caspase-9 activation in PRKCSH-deficient cells (Fig. 5b, c).